Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Probable ATP-dependent RNA helicase DDX20 (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3)

 DDX20_HUMAN             Reviewed;         824 AA.
Q9UHI6; B4DWV7; Q96F72; Q9NVM3; Q9UF59; Q9UIY0; Q9Y659;
01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
01-DEC-2000, sequence version 2.
25-OCT-2017, entry version 193.
RecName: Full=Probable ATP-dependent RNA helicase DDX20;
EC=3.6.4.13;
AltName: Full=Component of gems 3;
AltName: Full=DEAD box protein 20;
AltName: Full=DEAD box protein DP 103;
AltName: Full=Gemin-3;
Name=DDX20; Synonyms=DP103, GEMIN3;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), IDENTIFICATION IN THE CORE SMN
COMPLEX, INTERACTION WITH SNRPB; SNRPD2 AND SNRPD3, AND IDENTIFICATION
BY MASS SPECTROMETRY.
PubMed=10601333; DOI=10.1083/jcb.147.6.1181;
Charroux B., Pellizzoni L., Perkinson R.A., Shevchenko A., Mann M.,
Dreyfuss G.;
"Gemin3: a novel DEAD box protein that interacts with SMN, the spinal
muscular atrophy gene product, and a component of gems.";
J. Cell Biol. 147:1181-1194(1999).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH EBV EBNA2
AND EBV EBNA3C.
PubMed=10383418; DOI=10.1074/jbc.274.27.19136;
Grundhoff A.T., Kremmer E., Tuereci O., Glieden A., Gindorf C.,
Atz J., Mueller-Lantzsch N., Schubach W.H., Grasser F.A.;
"Characterization of DP103, a novel DEAD box protein that binds to the
Epstein-Barr virus nuclear proteins EBNA2 and EBNA3C.";
J. Biol. Chem. 274:19136-19144(1999).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
TISSUE=Esophagus;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=16710414; DOI=10.1038/nature04727;
Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
Beck S., Rogers J., Bentley D.R.;
"The DNA sequence and biological annotation of human chromosome 1.";
Nature 441:315-321(2006).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
THR-636.
TISSUE=Placenta;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 189-275 (ISOFORM 1).
TISSUE=Testis;
PubMed=17974005; DOI=10.1186/1471-2164-8-399;
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
"The full-ORF clone resource of the German cDNA consortium.";
BMC Genomics 8:399-399(2007).
[7]
INTERACTION WITH SNUPN; SMN1 AND SNRPB.
PubMed=12095920; DOI=10.1093/hmg/11.15.1785;
Narayanan U., Ospina J.K., Frey M.R., Hebert M.D., Matera A.G.;
"SMN, the spinal muscular atrophy protein, forms a pre-import snRNP
complex with snurportin1 and importin beta.";
Hum. Mol. Genet. 11:1785-1795(2002).
[8]
INTERACTION WITH PPP4R2.
PubMed=12668731; DOI=10.1242/jcs.00409;
Carnegie G.K., Sleeman J.E., Morrice N., Hastie C.J., Peggie M.W.,
Philp A., Lamond A.I., Cohen P.T.W.;
"Protein phosphatase 4 interacts with the survival of motor neurons
complex and enhances the temporal localisation of snRNPs.";
J. Cell Sci. 116:1905-1913(2003).
[9]
INTERACTION WITH FOXL2.
PubMed=16153597; DOI=10.1016/j.bbrc.2005.08.184;
Lee K., Pisarska M.D., Ko J.J., Kang Y., Yoon S., Ryou S.M., Cha K.Y.,
Bae J.;
"Transcriptional factor FOXL2 interacts with DP103 and induces
apoptosis.";
Biochem. Biophys. Res. Commun. 336:876-881(2005).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-688, AND IDENTIFICATION
BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=16964243; DOI=10.1038/nbt1240;
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
"A probability-based approach for high-throughput protein
phosphorylation analysis and site localization.";
Nat. Biotechnol. 24:1285-1292(2006).
[11]
FUNCTION IN SNRNP BIOGENESIS, AND IDENTIFICATION IN SMN-SM COMPLEX.
PubMed=18984161; DOI=10.1016/j.cell.2008.09.020;
Chari A., Golas M.M., Klingenhager M., Neuenkirchen N., Sander B.,
Englbrecht C., Sickmann A., Stark H., Fischer U.;
"An assembly chaperone collaborates with the SMN complex to generate
spliceosomal SnRNPs.";
Cell 135:497-509(2008).
[12]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-187; THR-552 AND
SER-714, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
Greff Z., Keri G., Stemmann O., Mann M.;
"Kinase-selective enrichment enables quantitative phosphoproteomics of
the kinome across the cell cycle.";
Mol. Cell 31:438-448(2008).
[13]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48; SER-500; SER-532;
THR-552; SER-652; SER-654; SER-656; SER-677; SER-678; SER-703; THR-705
AND SER-714, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=18669648; DOI=10.1073/pnas.0805139105;
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
Elledge S.J., Gygi S.P.;
"A quantitative atlas of mitotic phosphorylation.";
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
[14]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=19413330; DOI=10.1021/ac9004309;
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
Mohammed S.;
"Lys-N and trypsin cover complementary parts of the phosphoproteome in
a refined SCX-based approach.";
Anal. Chem. 81:4493-4501(2009).
[15]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-677; SER-678 AND
SER-703, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
TISSUE=Leukemic T-cell;
PubMed=19690332; DOI=10.1126/scisignal.2000007;
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
Rodionov V., Han D.K.;
"Quantitative phosphoproteomic analysis of T cell receptor signaling
reveals system-wide modulation of protein-protein interactions.";
Sci. Signal. 2:RA46-RA46(2009).
[16]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-672; SER-678 AND
SER-714, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
TISSUE=Cervix carcinoma;
PubMed=20068231; DOI=10.1126/scisignal.2000475;
Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
Mann M.;
"Quantitative phosphoproteomics reveals widespread full
phosphorylation site occupancy during mitosis.";
Sci. Signal. 3:RA3-RA3(2010).
[17]
IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
PubMed=21269460; DOI=10.1186/1752-0509-5-17;
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
"Initial characterization of the human central proteome.";
BMC Syst. Biol. 5:17-17(2011).
[18]
INTERACTION WITH PUM2 AND NANOS1.
PubMed=21800163; DOI=10.1007/s00418-011-0842-y;
Ginter-Matuszewska B., Kusz K., Spik A., Grzeszkowiak D.,
Rembiszewska A., Kupryjanczyk J., Jaruzelska J.;
"NANOS1 and PUMILIO2 bind microRNA biogenesis factor GEMIN3, within
chromatoid body in human germ cells.";
Histochem. Cell Biol. 136:279-287(2011).
[19]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-505; SER-672; SER-677
AND SER-678, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
PubMed=21406692; DOI=10.1126/scisignal.2001570;
Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
Blagoev B.;
"System-wide temporal characterization of the proteome and
phosphoproteome of human embryonic stem cell differentiation.";
Sci. Signal. 4:RS3-RS3(2011).
[20]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268; SER-269; SER-505;
THR-552; SER-560; SER-672; SER-677; SER-678; SER-703; THR-705 AND
SER-714, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
ANALYSIS].
TISSUE=Cervix carcinoma, and Erythroleukemia;
PubMed=23186163; DOI=10.1021/pr300630k;
Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
Mohammed S.;
"Toward a comprehensive characterization of a human cancer cell
phosphoproteome.";
J. Proteome Res. 12:260-271(2013).
[21]
X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 41-268 IN COMPLEX WITH ADP,
AND ADP-BINDING.
PubMed=20510246; DOI=10.1016/j.jmb.2010.05.046;
Schutz P., Wahlberg E., Karlberg T., Hammarstrom M., Collins R.,
Flores A., Schuler H.;
"Crystal structure of human RNA helicase A (DHX9): structural basis
for unselective nucleotide base binding in a DEAD-box variant
protein.";
J. Mol. Biol. 400:768-782(2010).
[22]
X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 41-268.
PubMed=20941364; DOI=10.1371/journal.pone.0012791;
Schutz P., Karlberg T., van den Berg S., Collins R., Lehtio L.,
Hogbom M., Holmberg-Schiavone L., Tempel W., Park H.W.,
Hammarstrom M., Moche M., Thorsell A.G., Schuler H.;
"Comparative structural analysis of human DEAD-box RNA helicases.";
PLoS ONE 5:E12791-E12791(2010).
-!- FUNCTION: The SMN complex plays a catalyst role in the assembly of
small nuclear ribonucleoproteins (snRNPs), the building blocks of
the spliceosome. Thereby, plays an important role in the splicing
of cellular pre-mRNAs. Most spliceosomal snRNPs contain a common
set of Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF and
SNRPG that assemble in a heptameric protein ring on the Sm site of
the small nuclear RNA to form the core snRNP. In the cytosol, the
Sm proteins SNRPD1, SNRPD2, SNRPE, SNRPF and SNRPG are trapped in
an inactive 6S pICln-Sm complex by the chaperone CLNS1A that
controls the assembly of the core snRNP. Dissociation by the SMN
complex of CLNS1A from the trapped Sm proteins and their transfer
to an SMN-Sm complex triggers the assembly of core snRNPs and
their transport to the nucleus. May also play a role in the
metabolism of small nucleolar ribonucleoprotein (snoRNPs).
{ECO:0000269|PubMed:18984161}.
-!- CATALYTIC ACTIVITY: ATP + H(2)O = ADP + phosphate.
-!- SUBUNIT: Part of the core SMN complex that contains SMN1,
GEMIN2/SIP1, DDX20/GEMIN3, GEMIN4, GEMIN5, GEMIN6, GEMIN7, GEMIN8
and STRAP/UNRIP. Part of the SMN-Sm complex that contains SMN1,
GEMIN2/SIP1, DDX20/GEMIN3, GEMIN4, GEMIN5, GEMIN6, GEMIN7, GEMIN8,
STRAP/UNRIP and the Sm proteins SNRPB, SNRPD1, SNRPD2, SNRPD3,
SNRPE, SNRPF and SNRPG. Interacts directly with GEMIN5. Interacts
directly with SNUPN. Interacts with PPP4R2. Interacts with FOXL2.
Interacts with EBV EBNA2 and EBNA3C. Interacts with NANOS1 and
PUM2. {ECO:0000269|PubMed:10383418, ECO:0000269|PubMed:10601333,
ECO:0000269|PubMed:12095920, ECO:0000269|PubMed:12668731,
ECO:0000269|PubMed:16153597, ECO:0000269|PubMed:18984161,
ECO:0000269|PubMed:20510246, ECO:0000269|PubMed:21800163}.
-!- INTERACTION:
P57678:GEMIN4; NbExp=5; IntAct=EBI-347658, EBI-356700;
-!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus, gem. Note=Localized in
subnuclear structures next to coiled bodies, called Gemini of
Cajal bodies (Gems).
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=Q9UHI6-1; Sequence=Displayed;
Name=2;
IsoId=Q9UHI6-2; Sequence=VSP_056505, VSP_056506;
Note=No experimental confirmation available.;
-!- TISSUE SPECIFICITY: Ubiquitous.
-!- SIMILARITY: Belongs to the DEAD box helicase family. DDX20
subfamily. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
-----------------------------------------------------------------------
EMBL; AF171063; AAF14544.1; -; mRNA.
EMBL; AF106019; AAD42744.1; -; mRNA.
EMBL; AK001506; BAA91727.1; -; mRNA.
EMBL; AK301697; BAG63169.1; -; mRNA.
EMBL; AL049557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC011556; AAH11556.1; -; mRNA.
EMBL; AL133598; CAB63734.2; -; mRNA.
CCDS; CCDS842.1; -. [Q9UHI6-1]
PIR; T43476; T43476.
RefSeq; NP_009135.4; NM_007204.4. [Q9UHI6-1]
UniGene; Hs.591405; -.
PDB; 2OXC; X-ray; 1.30 A; A/B=41-268.
PDB; 3B7G; X-ray; 1.90 A; A/B=41-268.
PDBsum; 2OXC; -.
PDBsum; 3B7G; -.
ProteinModelPortal; Q9UHI6; -.
SMR; Q9UHI6; -.
BioGrid; 116387; 86.
CORUM; Q9UHI6; -.
DIP; DIP-32606N; -.
IntAct; Q9UHI6; 31.
MINT; MINT-96973; -.
STRING; 9606.ENSP00000358716; -.
iPTMnet; Q9UHI6; -.
PhosphoSitePlus; Q9UHI6; -.
BioMuta; DDX20; -.
DMDM; 12643886; -.
EPD; Q9UHI6; -.
PaxDb; Q9UHI6; -.
PeptideAtlas; Q9UHI6; -.
PRIDE; Q9UHI6; -.
DNASU; 11218; -.
Ensembl; ENST00000369702; ENSP00000358716; ENSG00000064703. [Q9UHI6-1]
Ensembl; ENST00000533164; ENSP00000434085; ENSG00000064703. [Q9UHI6-2]
GeneID; 11218; -.
KEGG; hsa:11218; -.
UCSC; uc001ebs.4; human. [Q9UHI6-1]
CTD; 11218; -.
DisGeNET; 11218; -.
EuPathDB; HostDB:ENSG00000064703.11; -.
GeneCards; DDX20; -.
HGNC; HGNC:2743; DDX20.
HPA; CAB015427; -.
HPA; HPA005516; -.
HPA; HPA023541; -.
MIM; 606168; gene.
neXtProt; NX_Q9UHI6; -.
OpenTargets; ENSG00000064703; -.
PharmGKB; PA27209; -.
eggNOG; KOG4284; Eukaryota.
eggNOG; COG0513; LUCA.
GeneTree; ENSGT00830000128348; -.
HOGENOM; HOG000112184; -.
HOVERGEN; HBG051330; -.
InParanoid; Q9UHI6; -.
KO; K13131; -.
OMA; QDYEEYW; -.
OrthoDB; EOG091G0461; -.
PhylomeDB; Q9UHI6; -.
TreeFam; TF352222; -.
Reactome; R-HSA-191859; snRNP Assembly.
SIGNOR; Q9UHI6; -.
EvolutionaryTrace; Q9UHI6; -.
GeneWiki; DDX20; -.
GenomeRNAi; 11218; -.
PRO; PR:Q9UHI6; -.
Proteomes; UP000005640; Chromosome 1.
Bgee; ENSG00000064703; -.
CleanEx; HS_DDX20; -.
ExpressionAtlas; Q9UHI6; baseline and differential.
Genevisible; Q9UHI6; HS.
GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
GO; GO:0005856; C:cytoskeleton; TAS:ProtInc.
GO; GO:0005829; C:cytosol; IDA:UniProtKB.
GO; GO:0097504; C:Gemini of coiled bodies; IEA:UniProtKB-SubCell.
GO; GO:0016020; C:membrane; IDA:UniProtKB.
GO; GO:0016604; C:nuclear body; IDA:HPA.
GO; GO:0005730; C:nucleolus; IBA:GO_Central.
GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
GO; GO:0005634; C:nucleus; IDA:HPA.
GO; GO:0090571; C:RNA polymerase II transcription repressor complex; IEA:Ensembl.
GO; GO:0032797; C:SMN complex; IDA:UniProtKB.
GO; GO:0034719; C:SMN-Sm protein complex; IDA:UniProtKB.
GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
GO; GO:0004004; F:ATP-dependent RNA helicase activity; TAS:ProtInc.
GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
GO; GO:0042826; F:histone deacetylase binding; IEA:Ensembl.
GO; GO:0030674; F:protein binding, bridging; IEA:Ensembl.
GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
GO; GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL.
GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
GO; GO:0051170; P:nuclear import; TAS:Reactome.
GO; GO:0048477; P:oogenesis; IEA:Ensembl.
GO; GO:0043065; P:positive regulation of apoptotic process; IGI:MGI.
GO; GO:0050810; P:regulation of steroid biosynthetic process; IEA:Ensembl.
GO; GO:0006396; P:RNA processing; TAS:ProtInc.
GO; GO:0010501; P:RNA secondary structure unwinding; IBA:GO_Central.
GO; GO:0000387; P:spliceosomal snRNP assembly; IDA:UniProtKB.
GO; GO:0000244; P:spliceosomal tri-snRNP complex assembly; TAS:ProtInc.
CDD; cd00079; HELICc; 1.
InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
InterPro; IPR014001; Helicase_ATP-bd.
InterPro; IPR001650; Helicase_C.
InterPro; IPR027417; P-loop_NTPase.
InterPro; IPR000629; RNA-helicase_DEAD-box_CS.
InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
Pfam; PF00270; DEAD; 1.
Pfam; PF00271; Helicase_C; 1.
SMART; SM00487; DEXDc; 1.
SMART; SM00490; HELICc; 1.
SUPFAM; SSF52540; SSF52540; 1.
PROSITE; PS00039; DEAD_ATP_HELICASE; 1.
PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
PROSITE; PS51194; HELICASE_CTER; 1.
PROSITE; PS51195; Q_MOTIF; 1.
1: Evidence at protein level;
3D-structure; Alternative splicing; ATP-binding; Complete proteome;
Cytoplasm; DNA-binding; Helicase; Hydrolase; mRNA processing;
mRNA splicing; Nucleotide-binding; Nucleus; Phosphoprotein;
Polymorphism; Reference proteome.
CHAIN 1 824 Probable ATP-dependent RNA helicase
DDX20.
/FTId=PRO_0000055025.
DOMAIN 93 264 Helicase ATP-binding.
{ECO:0000255|PROSITE-ProRule:PRU00541}.
DOMAIN 299 448 Helicase C-terminal.
{ECO:0000255|PROSITE-ProRule:PRU00542}.
NP_BIND 109 114 ATP.
REGION 456 548 SMN interacting.
MOTIF 62 90 Q motif.
MOTIF 211 214 DEAD box.
BINDING 84 84 ATP; via carbonyl oxygen.
BINDING 89 89 ATP.
MOD_RES 48 48 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 187 187 Phosphoserine.
{ECO:0000244|PubMed:18691976}.
MOD_RES 268 268 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 269 269 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 500 500 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 505 505 Phosphoserine.
{ECO:0000244|PubMed:21406692,
ECO:0000244|PubMed:23186163}.
MOD_RES 532 532 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 552 552 Phosphothreonine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:18691976,
ECO:0000244|PubMed:23186163}.
MOD_RES 560 560 Phosphoserine.
{ECO:0000244|PubMed:23186163}.
MOD_RES 652 652 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 654 654 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 656 656 Phosphoserine.
{ECO:0000244|PubMed:18669648}.
MOD_RES 672 672 Phosphoserine.
{ECO:0000244|PubMed:20068231,
ECO:0000244|PubMed:21406692,
ECO:0000244|PubMed:23186163}.
MOD_RES 677 677 Phosphoserine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:19690332,
ECO:0000244|PubMed:21406692,
ECO:0000244|PubMed:23186163}.
MOD_RES 678 678 Phosphoserine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:19690332,
ECO:0000244|PubMed:20068231,
ECO:0000244|PubMed:21406692,
ECO:0000244|PubMed:23186163}.
MOD_RES 688 688 Phosphothreonine.
{ECO:0000244|PubMed:16964243}.
MOD_RES 703 703 Phosphoserine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:19690332,
ECO:0000244|PubMed:23186163}.
MOD_RES 705 705 Phosphothreonine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:23186163}.
MOD_RES 714 714 Phosphoserine.
{ECO:0000244|PubMed:18669648,
ECO:0000244|PubMed:18691976,
ECO:0000244|PubMed:20068231,
ECO:0000244|PubMed:23186163}.
VAR_SEQ 133 138 ILILAP -> AELSNS (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_056505.
VAR_SEQ 139 824 Missing (in isoform 2).
{ECO:0000303|PubMed:14702039}.
/FTId=VSP_056506.
VARIANT 636 636 I -> T (in dbSNP:rs197412).
{ECO:0000269|PubMed:15489334}.
/FTId=VAR_057231.
VARIANT 693 693 R -> S (in dbSNP:rs197414).
/FTId=VAR_057232.
VARIANT 762 762 I -> T (in dbSNP:rs85276).
/FTId=VAR_057233.
CONFLICT 5 5 F -> V (in Ref. 2; AAD42744).
{ECO:0000305}.
CONFLICT 279 279 Y -> C (in Ref. 3; BAA91727).
{ECO:0000305}.
CONFLICT 639 639 R -> K (in Ref. 1; AAF14544).
{ECO:0000305}.
CONFLICT 659 659 Y -> H (in Ref. 2; AAD42744).
{ECO:0000305}.
CONFLICT 676 676 G -> S (in Ref. 1; AAF14544).
{ECO:0000305}.
CONFLICT 703 703 S -> T (in Ref. 1; AAF14544).
{ECO:0000305}.
HELIX 64 67 {ECO:0000244|PDB:2OXC}.
HELIX 71 79 {ECO:0000244|PDB:2OXC}.
HELIX 87 97 {ECO:0000244|PDB:2OXC}.
STRAND 102 105 {ECO:0000244|PDB:2OXC}.
HELIX 112 123 {ECO:0000244|PDB:2OXC}.
STRAND 133 136 {ECO:0000244|PDB:2OXC}.
HELIX 140 153 {ECO:0000244|PDB:2OXC}.
TURN 154 156 {ECO:0000244|PDB:2OXC}.
STRAND 162 165 {ECO:0000244|PDB:2OXC}.
HELIX 171 177 {ECO:0000244|PDB:2OXC}.
STRAND 182 186 {ECO:0000244|PDB:2OXC}.
HELIX 188 196 {ECO:0000244|PDB:2OXC}.
HELIX 202 204 {ECO:0000244|PDB:2OXC}.
STRAND 207 212 {ECO:0000244|PDB:2OXC}.
HELIX 213 217 {ECO:0000244|PDB:2OXC}.
HELIX 223 232 {ECO:0000244|PDB:2OXC}.
STRAND 238 244 {ECO:0000244|PDB:2OXC}.
HELIX 248 254 {ECO:0000244|PDB:2OXC}.
TURN 255 257 {ECO:0000244|PDB:2OXC}.
STRAND 262 264 {ECO:0000244|PDB:2OXC}.
SEQUENCE 824 AA; 92241 MW; 76712F014B2A0CF2 CRC64;
MAAAFEASGA LAAVATAMPA EHVAVQVPAP EPTPGPVRIL RTAQDLSSPR TRTGDVLLAE
PADFESLLLS RPVLEGLRAA GFERPSPVQL KAIPLGRCGL DLIVQAKSGT GKTCVFSTIA
LDSLVLENLS TQILILAPTR EIAVQIHSVI TAIGIKMEGL ECHVFIGGTP LSQDKTRLKK
CHIAVGSPGR IKQLIELDYL NPGSIRLFIL DEADKLLEEG SFQEQINWIY SSLPASKQML
AVSATYPEFL ANALTKYMRD PTFVRLNSSD PSLIGLKQYY KVVNSYPLAH KVFEEKTQHL
QELFSRIPFN QALVFSNLHS RAQHLADILS SKGFPAECIS GNMNQNQRLD AMAKLKHFHC
RVLISTDLTS RGIDAEKVNL VVNLDVPLDW ETYMHRIGRA GRFGTLGLTV TYCCRGEEEN
MMMRIAQKCN INLLPLPDPI PSGLMEECVD WDVEVKAAVH TYGIASVPNQ PLKKQIQKIE
RTLQIQKAHG DHMASSRNNS VSGLSVKSKN NTKQKLPVKS HSECGIIEKA TSPKELGCDR
QSEEQMKNSV QTPVENSTNS QHQVKEALPV SLPQIPCLSS FKIHQPYTLT FAELVEDYEH
YIKEGLEKPV EIIRHYTGPG DQTVNPQNGF VRNKVIEQRV PVLASSSQSG DSESDSDSYS
SRTSSQSKGN KSYLEGSSDN QLKDSESTPV DDRISLEQPP NGSDTPNPEK YQESPGIQMK
TRLKEGASQR AKQSRRNLPR RSSFRLQTEA QEDDWYDCHR EIRLSFSDTY QDYEEYWRAY
YRAWQEYYAA ASHSYYWNAQ RHPSWMAAYH MNTIYLQEMM HSNQ


Related products :

Catalog number Product name Quantity
EIAAB10764 Component of gems 3,DDX20,DEAD box protein 20,DEAD box protein DP 103,DP103,GEMIN3,Gemin-3,Homo sapiens,Human,Probable ATP-dependent RNA helicase DDX20
EIAAB10763 Component of gems 3,Ddx20,DEAD box protein 20,DEAD box protein DP 103,Dp103,Gemin3,Gemin-3,Mouse,Mus musculus,Probable ATP-dependent RNA helicase DDX20,Regulator of steroidogenic factor 1,ROSF-1
20-272-190175 Gemin 3 - Mouse monoclonal [12H12] to Gemin 3; EC 3.6.1.-; DEAD box protein 20; DEAD box protein DP 103; Component of gems 3; Gemin-3 Monoclonal 0.05 ml
EIAAB10824 ATP-dependent 61 kDa nucleolar RNA helicase,DDX21,DDX56,DEAD box protein 21,DEAD box protein 56,Homo sapiens,Human,NOH61,Probable ATP-dependent RNA helicase DDX56
EIAAB10806 Ddx5,DEAD box protein 5,DEAD box RNA helicase DEAD1,mDEAD1,Mouse,Mus musculus,Probable ATP-dependent RNA helicase DDX5,RNA helicase p68,Tnz2
EIAAB10759 DDX17,DEAD box protein 17,DEAD box protein p72,Homo sapiens,Human,Probable ATP-dependent RNA helicase DDX17,RNA-dependent helicase p72
EIAAB10791 ABS,DDX41,DEAD box protein 41,DEAD box protein abstrakt homolog,Homo sapiens,Human,Probable ATP-dependent RNA helicase DDX41
EIAAB10794 ATP-dependent RNA helicase DDX42,DDX42,DEAD box protein 42,Homo sapiens,Human,RHELP,RNA helicase-like protein,RNA helicase-related protein,RNAHP,SF3b DEAD box protein,SF3b125,Splicing factor 3B-associ
EIAAB10815 CAGE,Cancer_testis antigen 26,Cancer-associated gene protein,CT26,DDX53,DEAD box protein 53,DEAD box protein CAGE,Homo sapiens,Human,Probable ATP-dependent RNA helicase DDX53
18-003-42773 Probable ATP-dependent RNA helicase DDX6 - EC 3.6.1.-; DEAD box protein 6; ATP-dependent RNA helicase p54; Oncogene RCK Polyclonal 0.1 mg Protein A
EIAAB10817 ATP-dependent RNA helicase DDX54,ATP-dependent RNA helicase DP97,DDX54,DEAD box protein 54,DEAD box RNA helicase 97 kDa,Homo sapiens,Human
18-003-42772 Probable ATP-dependent RNA helicase DDX5 - EC 3.6.1.-; DEAD box protein 5; RNA helicase p68 Polyclonal 0.1 mg Protein A
18-003-42771 Probable ATP-dependent RNA helicase DDX5 - EC 3.6.1.-; DEAD box protein 5; RNA helicase p68 Polyclonal 0.1 mg Protein A
EIAAB10782 ATP-dependent RNA helicase DDX3X,DBX,DDX3,DDX3X,DEAD box protein 3, X-chromosomal,DEAD box, X isoform,Helicase-like protein 2,HLP2,Homo sapiens,Human
EIAAB10796 Cancer_testis antigen 13,CT13,DDX43,DEAD box protein 43,DEAD box protein HAGE,HAGE,Helical antigen,Homo sapiens,Human,Probable ATP-dependent RNA helicase DDX43
EIAAB10697 ATP-dependent RNA helicase DDX19B,DBP5,DDX19,DDX19B,DEAD box protein 19B,DEAD box RNA helicase DEAD5,Homo sapiens,Human,TDBP
EIAAB12133 ATP-dependent RNA helicase DDX39A,Ddx39,Ddx39a,Ddxl,DEAD box protein 39,Nuclear RNA helicase, DECD variant of DEAD box family,Rat,Rattus norvegicus
EIAAB10823 ATP-dependent 61 kDa nucleolar RNA helicase,D11Ertd619e,Ddx56,DEAD box protein 56,Mouse,Mus musculus,Noh61,Probable ATP-dependent RNA helicase DDX56
EIAAB10832 ATP-dependent RNA helicase p54,Ddx6,DEAD box protein 6,Hlr2,Mouse,Mus musculus,Oncogene RCK homolog,Probable ATP-dependent RNA helicase DDX6,Rck
EIAAB10831 ATP-dependent RNA helicase p54,DDX6,DEAD box protein 6,HLR2,Homo sapiens,Human,Oncogene RCK,Probable ATP-dependent RNA helicase DDX6,RCK
EIAAB10696 ATP-dependent RNA helicase DDX19A,Ddx19,Ddx19a,DEAD box protein 19A,DEAD box RNA helicase DEAD5,Eif4a-rs1,Eukaryotic translation initiation factor 4A-related sequence 1,mDEAD5,Mouse,Mus musculus
18-003-42786 Probable ATP-dependent RNA helicase DDX31 - EC 3.6.1.-; DEAD box protein 31; Helicain Polyclonal 0.1 mg Protein A
18-003-42841 Probable ATP-dependent RNA helicase DDX46 - EC 3.6.1.-; DEAD box protein 46; PRP5 homolog Polyclonal 0.1 mg Protein A
18-003-42776 Probable ATP-dependent RNA helicase DDX23 - EC 3.6.1.-; DEAD box protein 23; 100 kDa U5 snRNP-specific protein; U5-100kD; PRP28 homolog Polyclonal 0.1 mg Protein A
EIAAB10797 Ddx46,DEAD box protein 46,Hel117,Helicase of 117.4 kDa,Probable ATP-dependent RNA helicase DDX46,Rat,Rattus norvegicus


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur